Tag Archives: (UNH)

Leaning On The Knobs

I still remember sitting in a conference room in D.C. years ago, listening to a CMS official explain – with a perfectly straight face – that a 0.5% rate increase was “quite generous given the fiscal environment.” The insurers in the room did a great job of not laughing. Fast-forward to today, and Humana (HUM) […]

This Biopharma Is Cleared For A Long-Term Climb

UnitedHealth (UNH) is like a Boeing 747 in a thunderstorm: big, complicated, a little bumpy right now but still very much airborne, with the engines humming stronger than most investors realize. The recent clobbering of UNH shares has more to do with short-term panic than long-term fundamentals. If you’re in this game for quick thrills, […]

The Orchard Strategy

Last month, I was in my doctor’s waiting room, watching the receptionist wrestle with three different computer systems just to book my checkup. She clicked through windows that looked like they belonged on a floppy disk. “This is why healthcare costs so much,” I thought. What I didn’t realize then was that I was watching […]

Enjoying This Healthcare Giant’s Terrible, Horrible, No Good, Very Bad Year

Listen, I’ve been around this market long enough to remember when healthcare stocks were boring dividend plays that our parents owned for the steady income. Well, times have changed, and so has UnitedHealthcare (UNH), but sometimes the old investing wisdom still applies: buy when there’s blood in the streets, especially when it’s someone else’s blood. […]

When Healthcare’s Heavyweight Takes A Haymaker

You’ve spent decades building a sensible portfolio, weathered the dot-com crash, survived 2008, and now you’re eyeing healthcare stocks like UnitedHealth (UNH) because, well, people always need healthcare, right? Then suddenly this $300 billion giant hits a pothole so hard it rattles every healthcare investment from here to Boca Raton. Welcome to the new reality, […]